Patent ID: 11884663
Assignee: ACER THERAPEUTICS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC C

Claim 22:
23. A method of treating a viral infection in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a crystalline form of claim 1, wherein the viral infection is caused by Zika virus (ZIKV), Ebola virus (EBOV), Rabies lyssavirus (RABV), cytomegalovirus (CMV), human immunodeficiency virus 1 (HIV-1), influenza A virus, Rift Valley fever virus (RVFV), echovirus 1 (EV1), human metapneumorivus (HMPV), or herpes simplex virus type 2 (HSV-2).